宫颈癌放化疗后并发治疗相关性骨髓增生异常综合征/急性髓系白血病一例报告并文献复习
被引量:3
摘要
宫颈癌是妇科常见肿瘤之一,经手术联合放、化疗综合治疗,患者生存期显著延长,5年生存率达77.52%^[1]。治疗相关性骨髓增生异常综合征(MDS)/急性髓系白血病(AML)是长期存活患者的远期并发症之一,但目前尚无其发病率的流行病学研究^[2]。我们报道1例宫颈癌放、化疗后并发治疗相关性MDS/AML患者,并进行了文献复习。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2012年第2期138-140,共3页
Chinese Journal of Hematology
基金
国家自然科学基金(81070403)
参考文献23
-
1廖震华,陈增春,陈桂林,黄燕玲,陈炜,魏东红,田俊.190例宫颈癌患者临床病理特征及预后分析[J].中国肿瘤,2010,19(4):283-286. 被引量:13
-
2Chaturvedi AK,Engels EA,Gilbert ES,et al.Second cancers among 104760 survivors of cervical cancer:evaluation of long-term risk.J Natl Cancer Inst,2007,99:1634-1643.
-
3杨艺红,徐泽锋,张乃红,郝玉书,肖志坚.一例多发性骨髓瘤治疗相关性骨髓增生异常综合征[J].中华血液学杂志,2008,29(4):270-271. 被引量:9
-
4Leone G,Pagano L,Ben-yehuda D,et al.Therapy-related leukemia and myelodysplasia:susceptibility and incidence.Haematologica,2007,92:1389-1398.
-
5Smith SM,Le Beau MM,Huo D,et al.Clinical-cytogenetics associations in 306 patients with therapy-related myelodysplastic and myeloid leukemia:the University of Chicago series. Blood,2003,102:43-52.
-
6Leone G,Fianchi L,Pagano L,et al.Incidence and susceptibilty to therapy-related myeloid neoplasms.Chem Biol Interact,2010,184:39-45.
-
7Travis LB,Holowaty E J,Bergfeldt K,et al.Risk of leukemia after platinum-based chemotherapy for ovarian cancer.N Engl J Med,1999,340:351-357.
-
8McLaughlin P,Estey E,Glassman A,et al.Myelodysplastic and acute myeloid leukemia following therapy for indolent lymphoma with fludarabin,mitoxantrone,and dexamethasone(FND) plus rituximab and interferon alpha.Blood,2005,105:4573-4575.
-
9Metayer C,Curtis RE,Vose J,et al.Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma:a multicenter case-control.Blood,2003,101:2015-2023.
-
10Mays AN,Osheroff N,Xiao Y,et al.Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t (15; 17) therapy-related acute promyelocytic leukemia.Blood,2010,115:326-360.
二级参考文献15
-
1肖志坚.骨髓增生异常综合征的诊断和治疗认识现况[J].国际输血及血液学杂志,2007,30(1):1-4. 被引量:9
-
2Amiel A, Yukla M, Yogev S, et al. Deletion of 5q31 and 7q31 in patients with stable melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 2004, 152 : 84-87.
-
3Ishii Y, Hsiaoa HH, Sashidaa G, et al. Derivative (1;7)(q10; p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genet Cytogenet, 2006, 167: 131- 137.
-
4Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia, 2002, 16: 2366-2378.
-
5Rodjer S, Swolin B, Weinfeld A, et al. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 1990, 48 : 67-73.
-
6Nilsson T, Nilsson L, Lenhoff S, et al. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance : evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer, 2004, 41 : 223-231.
-
7Van DP, Lie AK, Vach W, et al. Risk grouping in stage Ⅰ b squamous cell cervical carcinoma [J]. Gynecol Oncol 2005, 99(1):106-112.
-
8Memarzadeh S, Natarajan S, Dandade DP, et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer[J]. Obstet Gynecol, 2003, 102(3): 612-619.
-
9Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy [J]. Gynecol Oncol, 2004, 93 (2):458-464.
-
10Peters Ⅲ WA, Liu R, Barrett Ⅱ R J, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix [J]. J Clin Oncol, 2000,18(8):1606-1613.
共引文献19
-
1陈晓红.青年妇女患宫颈癌的临床研究及预后分析[J].现代预防医学,2012,39(22):5832-5834. 被引量:11
-
2谭国柱,王秀娟.老年宫颈癌患者的临床病理特点及预后分析[J].实用癌症杂志,2014,29(1):66-71. 被引量:10
-
3孔令环,肖中平,王雪野,张光英.原粒增高与多发性骨髓瘤复发临床观察[J].中国误诊学杂志,2009,9(24):5814-5815.
-
4胡影,陈世伦,钟玉萍,李新,安娜,张佳佳.多发性骨髓瘤并发骨髓增生异常综合征1例并文献复习[J].临床血液学杂志,2010,23(4):407-408. 被引量:4
-
5王晗,高薇炜.子宫颈癌100例临床病理特征分析[J].蚌埠医学院学报,2011,36(11):1223-1224. 被引量:3
-
6刘艳丽.128例绝经后妇女宫颈癌的临床病理和预后分析[J].中国医药指南,2012,10(36):170-171. 被引量:3
-
7李芳,王颖.乳腺癌放化疗后并发治疗相关性急性单核细胞白血病1例报告并文献复习[J].中国实用医刊,2014,41(6):126-126.
-
8李芳,崔海玲.乳腺癌放化疗后继发急性淋巴细胞白血病2例并文献复习[J].国际医药卫生导报,2014,20(12):1736-1738. 被引量:3
-
9袁利梅,赵德英,邱惠,谢丛华,张弓,周福祥.影响宫颈癌患者预后的临床病理因素分析[J].山东医药,2014,54(25):21-23. 被引量:15
-
10简凤萍,陈昂.I-IIa期宫颈鳞状细胞癌患者术后随诊和复发情况分析[J].广州医药,2015,46(2):30-32. 被引量:2
同被引文献36
-
1王战营,郭宏岗,张莳,张艳灵,唐家宏.HAG方案治疗老年急性髓系白血病16例疗效分析[J].中国医师进修杂志,2012,35(S02):57-58. 被引量:3
-
2展昭民,陈德发,吴红菊,贡铁军,任实,郝文鹏,唐庆华,关小军,张伯龙,马军.治疗相关性白血病的治疗[J].癌症进展,2005,3(2):106-109. 被引量:12
-
3吴意红,祝文娟.预激方案治疗老年急性髓性白血病17例临床分析[J].安徽医药,2005,9(12):931-931. 被引量:1
-
4Leone G,Fianchi L,Pagano L,et al.Incidence and susceptibility totherapy-related myeloid neoplasms[J].Chem Biol Interact,2010,184(1/2):39-45.
-
5Smith SM,Le Beau MM,Huo D,et al.Clinical-cytogenetic associa-tions in 306 patients with therapy-related myelodysplasia and mye-loid leukemia:the University of Chicago series[J].Blood,2003,102(1):43-52.
-
6Howard RA, Gilbert ES, Chen BE, et al. Leukemia following breast cancer: an international population-based study of 376, 825 women[J]. Breast Cancer Res Treat, 2007, 105 (3): 359- 368.
-
7Praga C, Bergh J, Bliss J, et al. and myelodysplastic syndrome Risk of acute myeloid leukemia in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide [ J ]. J Clin Oncol, 2005, 23 (18): 4179-4191.
-
8Tallman MS, Gray R, Bennett JM, et al. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the East- em Cooperative Oncology Group experience [J]. J Clin Oncol, 1995, 13(7): 1557-1563.
-
9Valagussa P, Molitemi A, Terenziani M, et al. Second malignan- cies following CMF-based adjuvant chemotherapy in resectable breast cancer[J]. Ann Oncol, 1994, 5(9): 803-808.
-
10Curtis RE, Boice JD Jr, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer [Jl. N Engl J Med, 1992, 326(26): 1745-1751.
引证文献3
-
1罗贤生,王智明,黄海妹,陈晓霞.CAG方案用于治疗相关性急性髓系白血病诱导化疗的临床观察[J].安徽医药,2014,18(2):345-347. 被引量:9
-
2徐皓,魏旭东,尹青松,汪萍,米瑞华,艾昊,张丽娜,李玉富,朱兴虎,张丽,宋永平.乳腺癌治疗相关性急性白血病12例报告并文献复习[J].中华血液学杂志,2014,35(11):1018-1021. 被引量:5
-
3陈亨,蒋元强,沈云峰,陆米则,王菱菱,庄芸,杨国华.地西他滨联合小剂量HAG在老年急性髓系白血病患者中的应用[J].中国肿瘤临床与康复,2017,24(9):1074-1077. 被引量:7
二级引证文献21
-
1江庭秀,陈宏,阳洁,常捷,谢国然,彭梅.地西他滨联合小剂量HAG方案治疗老年急性髓系白血病的效果及对其免疫功能的影响[J].智慧健康,2020(14):126-128.
-
2李丽梅,吕鹏,周倩,乔蓉,徐慧霞,李玲,金阿荣.治疗相关髓系肿瘤10例临床特征[J].慢性病学杂志,2020(3):326-329.
-
3王成军,屈丽君,汪俭,李艳,许喆,程杰,王敏,高珊,王翔,陈天平.亮菌口服溶液辅助儿童白血病化疗的临床观察[J].安徽医药,2015,19(8):1595-1597.
-
4卢绮思,许娜,周璇,蔡耿喜,李琳,李玉玲,陆紫媛,黄继贤,刘启发,刘晓力.35例治疗相关血液肿瘤患者的临床特征及预后分析[J].中华血液学杂志,2016,37(3):221-226. 被引量:12
-
5张丽娟,苏丽萍.地西他滨联合CAG方案治疗老年急性髓系白血病的临床效果观察[J].临床医学研究与实践,2016,1(5):9-10. 被引量:16
-
6李萨萨,陶千山,蒲莲芳,李迎伟,翟志敏.超小剂量地西他滨治疗骨髓增生异常综合征的近期疗效和不良反应观察[J].安徽医药,2016,20(6):1174-1178. 被引量:11
-
7王秀明.参附注射液联合化疗治疗急性白血病的临床疗效[J].中国继续医学教育,2017,9(9):216-218.
-
8沈立云,马鸿雁,杨华.沙利度胺联合CAG方案治疗老年急性髓系白血病分析[J].系统医学,2016,1(7):44-46. 被引量:5
-
9徐悦,郑波.乳腺癌治疗相关血液肿瘤的临床研究进展[J].肿瘤,2017,37(10):1106-1111. 被引量:6
-
10把环环,刘心.恶性血液病继发第二肿瘤研究进展[J].现代肿瘤医学,2017,25(23):3878-3881. 被引量:3
-
1李婵娟,张翼鷟.治疗相关性骨髓增生异常综合征/急性髓系白血病研究进展[J].中国实验血液学杂志,2014,22(6):1757-1760. 被引量:16
-
2杨艺红,徐泽锋,张乃红,郝玉书,肖志坚.一例多发性骨髓瘤治疗相关性骨髓增生异常综合征[J].中华血液学杂志,2008,29(4):270-271. 被引量:9
-
3李占林.不吃药也能提高免疫力[J].家庭医药(就医选药),2010(2):54-54.
-
4张文芳,高云.中医及中西医结合治疗放化疗后白细胞减少症[J].现代中西医结合杂志,2002,11(24):2523-2525. 被引量:3
-
5高凤玲,武赤,林海涛.肺癌放化疗后合并侵袭性真菌病1例[J].中国实用内科杂志,2007,27(23):1888-1890.
-
6孙卫红.吸入性肺炎的诊治难点和对策[J].临床肺科杂志,2007,12(10):1123-1123.
-
7段玉波,林圣云,武利强,胡致平,戴铁颖,周郁鸿,倪桂宝.骨髓增生异常综合征与恶性淋巴瘤共存1例报道[J].江西医药,2010,45(1):41-43. 被引量:2
-
8黄秀芳,黄秀兰.穴位注射配合药物治疗放化疗后白细胞减少症90例[J].福建中医药,2003,34(6):44-45.
-
9浦权.骨髓增生异常综合征 第三讲治疗相关性骨髓增生异常综合征[J].新医学,1998,29(9):491-492.
-
10杨蓓蓓.变应性鼻炎和哮喘的治疗相关性[J].中国医学文摘(耳鼻咽喉科学),2009,24(2):98-98. 被引量:1